---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285957513.md"
description: "Heron Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results."
datetime: "2026-05-11T12:56:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285957513.md)
  - [en](https://longbridge.com/en/news/285957513.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285957513.md)
---

# 

Heron Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.

### Related Stocks

- [HRTX.US](https://longbridge.com/en/quote/HRTX.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis](https://longbridge.com/en/news/286899753.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility](https://longbridge.com/en/news/286050041.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)